Injectable generic drugs maker Hospira Inc said it plans to buy a factory and a research center from India-based Orchid Chemicals & Pharmaceuticals Ltd for $200 million. The factory, located in Aurangabad in India’s western state of Maharashtra manufactures active pharmaceutical ingredients. It was constructed in 2000 and has 640 employees. The R&D facility in the southern city of Chennai has about 160 scientific personnel.
Lake Forest, Illinois-based Hospira said it expects the acquisitions to reduce costs, help supply key antibiotic products and pave the way for development of active pharmaceutical ingredients.